Work

Abstract C169: Intermittent dosing of Imetelstat Sodium, a telomerase inhibitor, induces drug exposure consistent with in vivo tumor growth inhibition

Year: 2009

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-09-c169

Authors: Mark J. Ratain, Elisabeth Heath, Amy Weise, Laurence Elias, Fabio M. Benedetti, Jennifer A. Smith, Tong Lin, Zhu Pirot, Patricia LoRusso

Institutions: University of Chicago, The Barbara Ann Karmanos Cancer Institute, Geron (United States)

Language: English

Topic: Telomeres, Telomerase, and Senescence

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2050318271

Cites:

Cited by: 2

Related to: 10